Progress in the diagnosis of unstable angina and perspectives for treatment

Area of Science:

• Cardiology
• Biomarkers
• Emergency Medicine

Background:

• Unstable angina is a critical phase of coronary heart disease characterized by clinical symptoms.
• Electrocardiographic findings in unstable angina are diverse, with creatine kinase elevations being infrequent.
• Minor myocardial cell injury in unstable angina is often indicated by troponin T and troponin I elevation in 30-40% of patients.

Purpose of the Study:

• To evaluate troponins as superior biomarkers for identifying high-risk patients with unstable angina.
• To explore the role of troponins in guiding therapeutic decisions for unstable angina management.
• To assess the utility of troponins in emergency room risk stratification for coronary heart disease.

Main Methods:

• Review of recent studies documenting the efficacy of troponins in unstable angina.
• Analysis of troponin T and troponin I levels in patients presenting with angina at rest.
• Correlation of troponin levels with patient outcomes and response to specific treatments.

Main Results:

• Troponins are identified as the most effective markers for high-risk unstable angina patients, excluding other serious conditions.
• Elevated troponin levels are observed in approximately 30-40% of patients with angina at rest.
• Early evidence suggests that only patients with elevated troponins benefit from prolonged treatment with low molecular weight heparin or glycoprotein IIb/IIIa receptor blockers.

Conclusions:

• Troponin testing is crucial for accurate risk stratification in unstable angina patients.
• Troponins serve as key indicators for identifying patients who will benefit from advanced therapies.
• Implementing troponin assays in emergency settings can optimize treatment strategies for high-risk cardiovascular patients.